{"disease":{"id":"pulmonary-vascular-resistance-abnormality","name":"pulmonary vascular resistance abnormality"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06331208","title":"Mechanisms of Pulmonary Vascular Dysfunction in Heart Failure","phase":"","overall_status":"RECRUITING","enrollment_count":230,"lead_sponsor_name":"Institute for Clinical and Experimental Medicine","has_results":false},{"nct_id":"NCT05484596","title":"PV Loop and Pulmonary Hypertension","phase":"","overall_status":"UNKNOWN","enrollment_count":65,"lead_sponsor_name":"Hythem Nawaytou","has_results":false},{"nct_id":"NCT03404258","title":"ET1 Concentration, Metabolic Pathway Activation, and Pulmonary Blood Flow in Infants Undergoing Superior Cavo-Pulmonary Anastomosis","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT04599816","title":"Levosimendan Administration in Pulmonary Hypertension","phase":"NA","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"Aretaieion University Hospital","has_results":false},{"nct_id":"NCT04718350","title":"Treatment of Pulmonary Hypertension in High-risk Cardiac Surgery Patients Using Inhalational and Intravenous Agents","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Aretaieion University Hospital","has_results":false},{"nct_id":"NCT03707249","title":"Iron Status and Cardiopulmonary Physiology","phase":"NA","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Royal Centre for Defence Medicine","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}